News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Sanofi-Aventis (France) Recalls 800000 H1N1 Vaccine Over Potency
December 15, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BOSTON (MarketWatch) -- Sanofi-Aventis is recalling about 800,000 doses of its U.S.-distributed H1N1 vaccine for children after tests showed that certain batches had lost their potency over time, the Centers for Disease Control said Tuesday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Sanofi (France)
MORE ON THIS TOPIC
Podcast
Deals Roll at JPM26, Policy Front and Center, IPOs Are Back, FDA Stays Busy
January 14, 2026
·
2 min read
·
Heather McKenzie
Approvals
Sentynl, Fortress Bounce Back With FDA Approval for Rare Pediatric Disease
January 13, 2026
·
2 min read
·
Tristan Manalac
ADCs
Lung Cancer Trial to Proceed After FDA Releases Hold on Merck, Daiichi’s ADC
January 13, 2026
·
3 min read
·
Tristan Manalac
Regulatory
FDA Carves Out Manufacturing Exemptions for CGTs To Accelerate Development
January 12, 2026
·
2 min read
·
Tristan Manalac